Comparison between Kilitch Drugs (india) Rights Issue 2025 and Spandana Sphoorty Financial Rights Issue 2025.
Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Kilitch Drugs (india) Rights Issue 2025 and Spandana Sphoorty Financial Rights Issue 2025. Kilitch Drugs (india) Rights Issue 2025 is listed on BSE, NSE while Spandana Sphoorty Financial Rights Issue 2025 is listed on BSE, NSE.
| Kilitch Drugs (india) Ltd. | Spandana Sphoorty Financial Limited | |
|---|---|---|
| Logo |  |  |
| Listing At | BSE, NSE | BSE, NSE |
| Terms of Payment | The full amount of the Issue Price Rs 357/- will be payable on application. | Amount for Rights Equity Shares Rs. 115.00/- shall be payable by the eligible shareholders at the time of application, and the balance Rs. 115.00/- in the 1st and Final call, as determined by the Board in consultation with the Rights Issue Committee |
| Entitlement | 2 Rights Equity Share(s) for every 23 fully paid-up Equity Shares held on Record Date | 10 Rights Equity Share(s) for every 41 fully paid-up Equity Shares held on Record Date |
| Application Form | Application Form  | Application Form |
| Letter of Offer | Letter of Offer | Letter of Offer |
| Registrar | MUFG Intime India Pvt.Ltd. | Kfin Technologies Ltd. |
| Lead Managers |
The issue size of Kilitch Drugs (india) Rights Issue 2025 rights issue is ₹49.93 Crores, whereas Spandana Sphoorty Financial Rights Issue 2025 rights issue size is ₹400.00 Crores.
| Kilitch Drugs (india) Ltd. | Spandana Sphoorty Financial Limited | |
|---|---|---|
| Issue Size | 13,98,463 shares | 1,73,91,304 shares |
| Issue Size (Amount) | ₹49.93 Crores | ₹400.00 Crores |
| Issue Price | ₹357 per share | ₹230 per share |
| Face Value | ₹10 per share | ₹5 per share |
Find all the important dates related to the rights issue. The record date of Kilitch Drugs (india) Rights Issue 2025 is Jul 15, 2025 while record date of Spandana Sphoorty Financial Rights Issue 2025 is Jul 24, 2025.
| Kilitch Drugs (india) Ltd. | Spandana Sphoorty Financial Limited | |
|---|---|---|
| Record Date | Jul 15, 2025 | Jul 24, 2025 |
| Credit of Rights Entitlements | Jul 16, 2025 | Jul 25, 2025 |
| Bid/Offer Opens On | Jul 23, 2025 | Aug 01, 2025 |
| Renunciation of Rights Entitlements | Aug 18, 2025 | Aug 06, 2025 |
| Bid/Offer Closes On | Aug 21, 2025 | Aug 11, 2025 |
| Deemed Date of Allotment | Aug 22, 2025 | Aug 13, 2025 |
| Credit Date | Aug 26, 2025 | Aug 13, 2025 |
| Listing Date | Aug 28, 2025 | Aug 14, 2025 |
Comparison of Kilitch Drugs (india) Rights Issue 2025 and Spandana Sphoorty Financial Rights Issue 2025 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.
| Kilitch Drugs (india) Ltd. | Spandana Sphoorty Financial Limited | ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial | Kilitch Drugs (india) Ltd. Financial Information (Restated Consolidated)Kilitch Drugs (india) Ltd.'s revenue increased by 28% and profit after tax (PAT) rose by 84% between the financial year ending with March 31, 2025 and March 31, 2024.
| Spandana Sphoorty Financial Limited Financial Information (Restated Consolidated)Spandana Sphoorty Financial Limited's revenue decreased by 3% and profit after tax (PAT) dropped by 307% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||
